RVL Pharmaceuticals PLC RVLP

Market cap
$14.1M
P/E
0.0×
Older periods Sep '22 Dec '22 Mar '23 Jun '23
P/E ratio

+8 more quarters

0.00 0.00 0.00 0.00
P/S ratio
4.55 2.08 3.05 1.51
P/FCF ratio
0.00 0.00 0.00 0.00
P/Operating CF
(19.29) (6.28) (19.46) (4.61)
P/B ratio
2.84 2.02 2.83 3.41
EV/Sales
4.48 2.33 3.71 2.55
EV/EBITDA
0.00 0.00 0.00 0.00
EV/FCF
(4.20) (3.00) (4.26) (1.99)
Current Ratio
3.30 2.89 2.34 0.38
Net Debt/EBITDA
0.24 (1.54) (2.41) (4.81)
Debt/Equity
0.82 1.11 1.43 3.54
Earnings Yield
(29.52%) (48.70%) (52.63%) (125.00%)
Free Cash Flow Yield
(23.43%) (37.34%) (28.56%) (85.20%)
Free Cash Flow per Share
(0.11) (0.19) (0.07) (0.13)
Book value per Share
0.74 0.57 0.40 0.16
Free Cash Flow
(9.87) (17.48) (7.04) (13.02)
EV/EBIT
0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates